senior vice president of CURA sales and marketing, has already said to expect hundreds ofthousands of CURA B2B users next year at brand name companies and organizations, a media blitz is an unnecessary cost in my opinion. The direct sales method appears to be very effective, since the company has indicated to expect substantial results from it. A media blitz would only cause more dilutive equity for the current shareholder, thereby hurting the current shareholders.
I am not a marketing expert but the company's expert, Jim Donnelly, already affirmed an expectation -- hundreds of thousands B2B users -- based solely upon the current B2B pilots. He was specifically and exclusively talking B2B pilots. So if hundreds of thousands are expected based upon current pilots, is it unreasonable to extrapolate millions of B2B users from the same direct sales method going forward?
I considered the individual consumer market effort a timing mistake at this point, or even a red herring, when it was announced. Someone should ask about that, the reasoning of it. A successful B2B CURA deployment might even help CURA sell itself in the consumer market someday. 'Like, I got you this device that I use at my company...'.
Someone should also question what that ridiculous Cheddar and ROC TV effort was?
Why oh why then is a product with these expectations -- CURA -- allowing the company to still float a note with a 20 cent conversion?
News 
Market Data 
Discover 
AI
